Compare Medacta Group SA with Similar Stocks
Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 27.06% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 24
3
With ROE of 23.16%, it has a Very Expensive valuation with a 7.53 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.0%
0%
-3.0%
6 Months
2.06%
0%
2.06%
1 Year
13.07%
0%
13.07%
2 Years
23.18%
0%
23.18%
3 Years
51.07%
0%
51.07%
4 Years
32.15%
0%
32.15%
5 Years
41.98%
0%
41.98%
Medacta Group SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.90%
EBIT Growth (5y)
27.06%
EBIT to Interest (avg)
6.05
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
1.04
Tax Ratio
16.94%
Dividend Payout Ratio
19.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.61%
ROE (avg)
20.96%
Valuation key factors
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
7.53
EV to EBIT
30.25
EV to EBITDA
18.57
EV to Capital Employed
5.57
EV to Sales
5.19
PEG Ratio
0.52
Dividend Yield
NA
ROCE (Latest)
18.40%
ROE (Latest)
23.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
562.60
496.20
13.38%
Operating Profit (PBDIT) excl Other Income
149.80
130.60
14.70%
Interest
7.20
6.60
9.09%
Exceptional Items
-4.90
-1.80
-172.22%
Consolidate Net Profit
69.40
46.00
50.87%
Operating Profit Margin (Excl OI)
155.90%
150.40%
0.55%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 13.38% vs 13.08% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 50.87% vs -0.86% in Dec 2023
About Medacta Group SA 
Medacta Group SA
Pharmaceuticals & Biotechnology
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.






